Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Open-Label Study of BGB-A317 in Patients With Relapsed or Refractory Mature T- and NK-cell Neoplasms

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03493451
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:10.559009+00:00
Published At
2022-05-04T00:00:00+00:00
Record Updated At
2024-10-26
Results Posted At
2022-05-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Peripheral T Cell Lymphoma", "PTCL", "Extranodal NK/T-cell Lymphoma", "Extranodal NK/T-cell Lymphoma, Nasal Type", "Extranodal NK T Cell Lymphoma", "Extranodal NK T Cell Lymphoma, Nasal", "Adult Nasal Type Extranodal NK/T-cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "Angioimmunoblastic T-Cell Lymphoma Recurrent", "Angioimmunoblastic T-Cell Lymphoma Refractory", "Peripheral T-cell Lymphoma NOS", "Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Peripheral T-Cell Lymphoma Refractory", "Anaplastic Large Cell Lymphoma", "Anaplastic Large Cell Lymphoma, ALK-Positive", "Anaplastic Large Cell Lymphoma, ALK-negative", "ALK-negative Anaplastic Large Cell Lymphoma", "ALK-Positive Anaplastic Large Cell Lymphoma", "Cutaneous T-cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-10-26"
protocolSection.identificationModule.nctId
"NCT03493451"
protocolSection.identificationModule.officialTitle
"A Phase 2, Open-Label Study of BGB-A317 in Patients With Relapsed or Refractory Mature T- and NK-cell Neoplasms"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-05-04"

Study condition terms

  • Peripheral T Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • PTCL (protocolSection.conditionsModule.conditions)
  • Extranodal NK/T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Extranodal NK/T-cell Lymphoma, Nasal Type (protocolSection.conditionsModule.conditions)
  • Extranodal NK T Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Extranodal NK T Cell Lymphoma, Nasal (protocolSection.conditionsModule.conditions)
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Angioimmunoblastic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Angioimmunoblastic T-Cell Lymphoma Recurrent (protocolSection.conditionsModule.conditions)
  • Angioimmunoblastic T-Cell Lymphoma Refractory (protocolSection.conditionsModule.conditions)
  • Peripheral T-cell Lymphoma NOS (protocolSection.conditionsModule.conditions)
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified (protocolSection.conditionsModule.conditions)
  • Peripheral T-Cell Lymphoma Refractory (protocolSection.conditionsModule.conditions)
  • Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Anaplastic Large Cell Lymphoma, ALK-Positive (protocolSection.conditionsModule.conditions)
  • Anaplastic Large Cell Lymphoma, ALK-negative (protocolSection.conditionsModule.conditions)
  • ALK-negative Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • ALK-Positive Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Cutaneous T-cell Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.